APA (7th ed.) Citation

H, O., Y, Y., T, T., A, K., R, T., T, M., . . . T, W. (2019). Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma. Scientific reports, 9(1), 1281. https://doi.org/10.1038/s41598-019-39018-3

Chicago Style (17th ed.) Citation

H, Okamoto, et al. "Interleukin-13 Receptor α2 Is a Novel Marker and Potential Therapeutic Target for Human Melanoma." Scientific Reports 9, no. 1 (2019): 1281. https://doi.org/10.1038/s41598-019-39018-3.

MLA (9th ed.) Citation

H, Okamoto, et al. "Interleukin-13 Receptor α2 Is a Novel Marker and Potential Therapeutic Target for Human Melanoma." Scientific Reports, vol. 9, no. 1, 2019, p. 1281, https://doi.org/10.1038/s41598-019-39018-3.